Literature DB >> 25100846

The M33 G protein-coupled receptor encoded by murine cytomegalovirus is dispensable for hematogenous dissemination but is required for growth within the salivary gland.

Fabiola M Bittencourt1, Shu-En Wu1, James P Bridges2, William E Miller3.   

Abstract

Human cytomegalovirus (HCMV) is a pathogen found worldwide and is a serious threat to immunocompromised individuals and developing fetuses. Due to the species specificity of cytomegaloviruses, murine cytomegalovirus (MCMV) has been used as a model for in vivo studies of HCMV pathogenesis. The MCMV genome, like the genomes of other beta- and gammaherpesviruses, encodes G protein-coupled receptors (GPCRs) that modulate host signaling pathways presumably to facilitate viral replication and dissemination. Among these viral receptors, the M33 GPCR carried by MCMV is an activator of CREB, NF-κB, and phospholipase C-β signaling pathways and has been implicated in aspects of pathogenesis in vivo, including persistence in the salivary glands of BALB/c mice. In this study, we used immunocompetent nonobese diabetic (NOD) and immunocompromised NOD-scid-gamma (NSG) mice to further investigate the salivary gland defect exhibited by M33 deficiency. Interestingly, we demonstrate that virus with an M33 deletion (ΔM33) can replicate in the salivary gland of immunocompromised animals, albeit with a 400-fold growth defect compared with the growth of wild-type virus. Moreover, we determined that M33 does not have a role in cell-associated hematogenous dissemination but is required for viral amplification once the virus reaches the salivary gland. We conclude that the reduced replicative capacity of the ΔM33 virus is due to a specific defect occurring within the localized environment of the salivary gland. Importantly, since the salivary gland represents a site essential for persistence and horizontal transmission, an understanding of the mechanisms of viral replication within this site could lead to the generation of novel therapeutics useful for the prevention of HCMV spread. Importance: Human cytomegalovirus infects the majority of the American people and can reside silently in infected individuals for the duration of their lives. Under a number of circumstances, the virus can reactivate, leading to a variety of diseases in both adults and developing babies, and therefore, identifying the function of viral proteins is essential to understand how the virus spreads and causes disease. We aim to utilize animal models to study the function of an important class of viral proteins termed G protein-coupled receptors with the ultimate goal of developing inhibitors to these proteins that could one day be used to prevent viral spread.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25100846      PMCID: PMC4178735          DOI: 10.1128/JVI.01006-14

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  51 in total

1.  Products of US22 genes M140 and M141 confer efficient replication of murine cytomegalovirus in macrophages and spleen.

Authors:  L K Hanson; J S Slater; Z Karabekian; G Ciocco-Schmitt; A E Campbell
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

2.  Immune responses and cytokine induction in the development of severe hepatitis during acute infections with murine cytomegalovirus.

Authors:  J Trgovcich; D Stimac; B Polić; A Krmpotić; E Pernjak-Pugel; J Tomac; M Hasan; B Wraber; S Jonjić
Journal:  Arch Virol       Date:  2000       Impact factor: 2.574

3.  Virulence characteristics of murine cytomegalovirus in cell and organ cultures.

Authors:  M C Jordan; J L Takagi
Journal:  Infect Immun       Date:  1983-08       Impact factor: 3.441

4.  CD8-positive T lymphocytes specific for murine cytomegalovirus immediate-early antigens mediate protective immunity.

Authors:  M J Reddehase; W Mutter; K Münch; H J Bühring; U H Koszinowski
Journal:  J Virol       Date:  1987-10       Impact factor: 5.103

Review 5.  Cytomegalovirus in solid organ transplantation.

Authors:  R H Rubin
Journal:  Transpl Infect Dis       Date:  2001       Impact factor: 2.228

6.  Detection of murine cytomegalovirus DNA in circulating leukocytes harvested during acute infection of mice.

Authors:  J F Bale; M E O'Neil
Journal:  J Virol       Date:  1989-06       Impact factor: 5.103

7.  Mouse cytomegalovirus. Necrosis of infected and morphologically normal submaxillary gland acinar cells during termination of chronic infection.

Authors:  D Henson; A J Strano
Journal:  Am J Pathol       Date:  1972-07       Impact factor: 4.307

8.  Murine cytomegalovirus (CMV) M33 and human CMV US28 receptors exhibit similar constitutive signaling activities.

Authors:  Maria Waldhoer; Thomas N Kledal; Helen Farrell; Thue W Schwartz
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

Review 9.  Pathogenesis of murine cytomegalovirus infection.

Authors:  Astrid Krmpotic; Ivan Bubic; Bojan Polic; Pero Lucin; Stipan Jonjic
Journal:  Microbes Infect       Date:  2003-11       Impact factor: 2.700

10.  Site-restricted persistent cytomegalovirus infection after selective long-term depletion of CD4+ T lymphocytes.

Authors:  S Jonjić; W Mutter; F Weiland; M J Reddehase; U H Koszinowski
Journal:  J Exp Med       Date:  1989-04-01       Impact factor: 14.307

View more
  13 in total

1.  A little cooperation helps murine cytomegalovirus (MCMV) go a long way: MCMV co-infection rescues a chemokine salivary gland defect.

Authors:  Pranay Dogra; Mindy Miller-Kittrell; Elisabeth Pitt; Joseph W Jackson; Tom Masi; Courtney Copeland; Shuen Wu; William E Miller; Tim Sparer
Journal:  J Gen Virol       Date:  2016-09-13       Impact factor: 3.891

2.  Development of a Primary Human Cell Model for the Study of Human Cytomegalovirus Replication and Spread within Salivary Epithelium.

Authors:  Kristen M Morrison; Matthew J Beucler; Emily O Campbell; Margaret A White; Rachel E Boody; Keith C Wilson; William E Miller
Journal:  J Virol       Date:  2019-01-17       Impact factor: 5.103

3.  Methods for Studying the Function of Cytomegalovirus GPCRs.

Authors:  Christine M O'Connor; William E Miller
Journal:  Methods Mol Biol       Date:  2021

Review 4.  Emerging roles of cytomegalovirus-encoded G protein-coupled receptors during lytic and latent infection.

Authors:  Theresa Frank; Ina Niemann; Anna Reichel; Thomas Stamminger
Journal:  Med Microbiol Immunol       Date:  2019-03-21       Impact factor: 3.402

5.  The Mouse Cytomegalovirus G Protein-Coupled Receptor Homolog, M33, Coordinates Key Features of In Vivo Infection via Distinct Components of Its Signaling Repertoire.

Authors:  Jiawei Ma; Kimberley Bruce; Nicholas Davis-Poynter; Philip G Stevenson; Helen E Farrell
Journal:  J Virol       Date:  2021-12-08       Impact factor: 6.549

Review 6.  US28: HCMV's Swiss Army Knife.

Authors:  Benjamin A Krishna; William E Miller; Christine M O'Connor
Journal:  Viruses       Date:  2018-08-20       Impact factor: 5.048

7.  The Human Cytomegalovirus Chemokine vCXCL-1 Modulates Normal Dissemination Kinetics of Murine Cytomegalovirus In Vivo.

Authors:  Joseph W Jackson; Trevor J Hancock; Ellen LaPrade; Pranay Dogra; Eric R Gann; Thomas J Masi; Ravichandran Panchanathan; William E Miller; Steven W Wilhelm; Tim E Sparer
Journal:  mBio       Date:  2019-06-25       Impact factor: 7.867

8.  CMV-encoded GPCR pUL33 activates CREB and facilitates its recruitment to the MIE locus for efficient viral reactivation.

Authors:  Benjamin A Krishna; Amanda B Wass; Abigail L Dooley; Christine M O'Connor
Journal:  J Cell Sci       Date:  2021-01-25       Impact factor: 5.285

9.  Murine Cytomegalovirus Spreads by Dendritic Cell Recirculation.

Authors:  Helen E Farrell; Kimberley Bruce; Clara Lawler; Martha Oliveira; Rhonda Cardin; Nicholas Davis-Poynter; Philip G Stevenson
Journal:  mBio       Date:  2017-10-03       Impact factor: 7.867

Review 10.  There Is Always Another Way! Cytomegalovirus' Multifaceted Dissemination Schemes.

Authors:  Joseph W Jackson; Tim Sparer
Journal:  Viruses       Date:  2018-07-20       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.